Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Alexander K, Hakansson"'
Autor:
Melvin L. K. Chua, Alexander K. Hakansson, Enya H. W. Ong, Boon Hao Hong, Jing Jing Miao, Adelene Y. L. Sim, Janice S. H. Tan, Kah Min Tan, Gabrielle C. J. Lee, Kar Perng Low, Jeffrey K. L. Tuan, Terence W. K. Tan, Michael L. C. Wang, Joe P. S. Yeong, Michael C. S. Tan, Lui Shiong Lee, Ravindran Kanesvaran, Xin Zhao, Julian Ho, Daniel E. Spratt, Edward M. Schaeffer, Kae‐Jack Tay, Yang Liu, Elai Davicioni, Li Yan Khor
Publikováno v:
Cancer Communications, Vol 43, Iss 10, Pp 1164-1168 (2023)
Externí odkaz:
https://doaj.org/article/2820ad25f44944e88127d04999d57ac3
Autor:
Michael T, Schweizer, Lawrence, True, Roman, Gulati, Yibai, Zhao, William, Ellis, George, Schade, Bruce, Montgomery, Sonia, Goyal, Katie, Nega, Alexander K, Hakansson, Yang, Liu, Elai, Davicioni, Kenneth, Pienta, Peter S, Nelson, Daniel, Lin, Jonathan, Wright
Publikováno v:
Journal of Urology. 209:354-363
Active surveillance is a safe and effective strategy for men with lower-risk prostate cancer who want to avoid local therapy; however, many patients on active surveillance progress to active treatment (eg, prostatectomy or radiation). We hypothesized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2919ee505785b2d14ce412f76ec73c6
https://doi.org/10.1097/ju.0000000000003038
https://doi.org/10.1097/ju.0000000000003038
Autor:
Michael T. Schweizer, Lawrence True, Roman Gulati, Yibai Zhao, William Ellis, George Schade, Bruce Montgomery, Sonia Goyal, Katie Nega, Alexander K. Hakansson, Yang Liu, Elai Davicioni, Kenneth Pienta, Peter S. Nelson, Daniel Lin, Jonathan Wright
Publikováno v:
The Journal of urology. 209(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14880010d78468d8fa199719ca726c1d
https://pubmed.ncbi.nlm.nih.gov/36621992
https://pubmed.ncbi.nlm.nih.gov/36621992
Autor:
Ariel E. E. Marciscano, Alicia Dillard, Alexander K. Hakansson, Yang Liu, Elai Davicioni, Sydney Wolfe, Jim C. Hu, Douglas Scherr, Francesca Khani, Himanshu Nagar, Christopher Barbieri
Publikováno v:
Journal of Clinical Oncology. 41:371-371
371 Background: SBRT is a treatment option for men with prostate cancer. PREPARE-SBRT (NCT03663218) is a clinical trial testing the safety of neoadjuvant MRI-guided SBRT for men with high-risk localized prostate cancer. We leveraged paired samples fr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e837f1aea8c9d2ab75e5a99d25ae975b
https://doi.org/10.1200/jco.2023.41.6_suppl.371
https://doi.org/10.1200/jco.2023.41.6_suppl.371
Autor:
Adam B Weiner, Yang Liu, Alexander K. Hakansson, Xin Zhao, James Alexander Proudfoot, JJ Haijing Zhang, R. Jeffrey Karnes, Robert Benjamin Den, Amar Upadhyaya Kishan, Robert Evan Reiter, Anis Hamid, Ashley Ross, Phuoc T. Tran, Melvin L.K. Lee Kiang Chua, Daniel Eidelberg Spratt, Gerhardt Attard, Tamara L. Lotan, Christopher J Sweeney, Elai Davicioni, Edward M. Schaeffer
Publikováno v:
Journal of Clinical Oncology. 41:241-241
241 Background: We previously reported on the use of gene expression profiling to characterize four primary subtypes in an analysis of over 100,000 prostate cancer primary tumors. Here we examine these subtypes and response to radiation (RT) after pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f0b79828bd683500a55d0d8dc0c418f
https://doi.org/10.1200/jco.2023.41.6_suppl.241
https://doi.org/10.1200/jco.2023.41.6_suppl.241
Autor:
Himanshu Nagar, Alicia Dillard, Alexander K. Hakansson, Yang Liu, Elai Davicioni, Sydney Wolfe, Jim C. Hu, Douglas Scherr, Francesca Khani, Ariel E. E. Marciscano, Christopher Barbieri
Publikováno v:
Journal of Clinical Oncology. 41:375-375
375 Background: Pre-Prostatectomy MRI-Guided Stereotactic Body Radiotherapy for High-Risk Prostate Cancer Trial (PREPARE SBRT; NCT03663218) is an ongoing clinical trial testing the safety of preoperative MRI-guided SBRT for men with clinically locali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8877301dd887d37a6f79b98d0fdf633d
https://doi.org/10.1200/jco.2023.41.6_suppl.375
https://doi.org/10.1200/jco.2023.41.6_suppl.375
Autor:
Michael Thomas Schweizer, Roman Gulati, Yang Liu, Alexander K. Hakansson, Elai Davicioni, Lawrence True, William J. Ellis, George Schade, Robert B. Montgomery, Sonia Wadhera, Katie Nega, Kenneth J. Pienta, Peter Nelson, Jonathan L. Wright, Daniel W. Lin
Publikováno v:
Journal of Clinical Oncology. 40:267-267
267 Background: We previously reported the results of a Phase 2 study showing that a high proportion (59%) of men with PC being followed on AS will have a negative post-treatment biopsy after 90 days of apalutamide (Schweizer, et al. SUO Annual Meeti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf56a463ce51fdda97f542d82e8b894e
https://doi.org/10.1200/jco.2022.40.6_suppl.267
https://doi.org/10.1200/jco.2022.40.6_suppl.267
Autor:
Adelene Sim Yen Ling, Alexander K. Hakansson, Enya Hui Wen Ong, Amanda S.Y. Lau, Kar Perng Low, Tian Ren Wong, Nicole Tan, Janice Ser Huey Tan, Jeffrey K.L. Tuan, Terence Wee Kiat Tan, Michael L.C. Wang, Kae-Jack Tay, Joe Poh Sheng Yeong, Lui Shiong Lee, Ravindran Kanesvaran, Michael Chien Sheng Tan, Yang Liu, Elai Davicioni, Li Yan Khor, Melvin Lee Kiang Chua
Publikováno v:
Journal of Clinical Oncology. 40:273-273
273 Background: The Decipher 22-gene genomic classifier (GC) has been shown to predict for metastasis and survival in predominantly Caucasian and African-American men from Western cohorts. There is however little data on the clinical utility of GC in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b56420f74ab08e30655409eda66b65f
https://doi.org/10.1200/jco.2022.40.6_suppl.273
https://doi.org/10.1200/jco.2022.40.6_suppl.273